Skip to content
Crinetics Pharmaceuticals Inc icon

Crinetics Pharmaceuticals Inc

CRNXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$85.01

Today

+0.1%

YTD

+83.0%

About

Crinetics Pharmaceuticals Inc is a pharmaceutical company specialising in the development of novel therapeutics for endocrine diseases and endocrine-related cancers. The company operates on a global scale, targeting markets that need breakthrough treatments for rare conditions. Positioned in the biotechnology sector, Crinetics Pharmaceuticals Inc conducts research and development in new technologies for endocrine oncology such as acromegaly, diabetes and obesity. The company's development of therapeutics is based on a pipeline of oral nonpeptide new chemical entities that target a variety of endocrine diseases. Add CRNX stock to your eToro virtual portfolio.

Price chart
Closing price history for CRNX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-16.84
P/S (TTM)212.72
P/B (TTM)7.54
Market cap$9.01B
Cap tierMid-cap
Industry avg P/E-17.91

Profitability

Gross margin86.55%
EBIT margin-1302.52%
Net margin-481.15%
ROE-42.45%
ROA-38.42%

Earnings & Revenue

Revenue (TTM)$42.16M
Revenue growth (1Y)+2928.4%
EPS (TTM)-$5.05
Free cash flow$-425.18M
Total debt$47.19M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.11
Employees594
Next earnings5 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Crinetics Pharmaceuticals Inc (CRNX) | Dirk Kuyken